Amobarbital—a probe of hepatic drug oxidation in man | Zendy

Inaba T. | Zendy; Tang B. K. | Zendy; Endrenyi L. | Zendy; Kalow W. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Amobarbital—a probe of hepatic drug oxidation in man

Author(s) -

Inaba T.,

Tang B. K.,

Endrenyi L.,

Kalow W.

Publication year - 1976

Publication title -

clinical pharmacology and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.941

H-Index - 188

eISSN - 1532-6535

pISSN - 0009-9236

DOI - 10.1002/cpt1976204439

Subject(s) - amobarbital , chemistry , anesthesia , distribution (mathematics) , pharmacology , psychology , medicine , psychiatry , mathematics , epilepsy , mathematical analysis

Some aspects of the fate of amobarbital were investigated since this drug is being used as a probe to gauge drug oxidation in man. The mean ratio of' orally available over intravenously injected amobarbital was established as 0.99 ± 0.11 (SD), by comparing integrated concentration‐time curves, indicating complete absorption and absence of a first‐pass eff'ect. One subject ingested 200 mg of amobarbital sodium, and amobarbital concentrations in serum were monitored for 5 days thereafter. Elimination of amobarbital under these conditions followed first‐order kinetics. One subject ingested amobarbital 7 times over a period of 3 yr; plasma clearances (32.1 ± 1.8 [SD] ml/min) exhibited remarkable constancy, while biologic half/lives (26.5 ± 3.1 hr) and distribution volumes (73.6 ± 8.0 L) showed some fluctuation. The distribution of parameters of amobarbital elimination was investigated in 36 unrelated subjects. Amobarbital half‐lives (23.8 ± 6.7 hr) appeared to be normally distributed, while the clearances (36.7 ± 10.0 ml/min) might not follow a normal distribution.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research